Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (LFCR) Revenue
Annual & quarterly revenue history · segment & region breakdown
LFCR · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsLifecore Biomedical, Inc. trailing twelve-month (TTM) revenue is $0.14B, an increase of 0.47% year-over-year from $0.13B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-05-25 | $0.13B | +$0.00B | +0.47% |
| 2024-05-26 | $0.13B | +$0.02B | +24.20% |
| 2023-05-28 | $0.10B | -$0.01B | -7.19% |
| 2022-05-29 | $0.11B | +$0.01B | +10.31% |
| 2021-05-31 | $0.10B | -$0.06B | -36.98% |
| 2020-05-31 | $0.16B | -$0.40B | -71.29% |
| 2019-05-31 | $0.56B | +$0.03B | +6.36% |
| 2018-05-31 | $0.52B | -$0.01B | -1.51% |
| 2017-05-31 | $0.53B | -$0.01B | -1.63% |
| 2016-05-31 | $0.54B | +$0.00B | +0.34% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Lifecore Biomedical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Lifecore Biomedical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Lifecore Biomedical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LFCR revenue · 4 questionsLFCR's trailing twelve-month (TTM) revenue is $0.14B. That is an increase of 0.47% year-over-year from $0.13B in FY2025.
▸ Source: FMP · Lifecore Biomedical, Inc. SEC filings · GAAP · Lifecore Biomedical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026